z-logo
Premium
Characterization of the Early Antibody Response in Bovine Tuberculosis: MPB83 is an Early Target with Diagnostic Potential
Author(s) -
Mcnair J.,
Corbett D. M.,
Girvin R. M.,
Mackie D. P.,
Pollock J. M.
Publication year - 2001
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1046/j.1365-3083.2001.00874.x
Subject(s) - antigen , mycobacterium bovis , antibody , immunogen , monoclonal antibody , bovine tuberculosis , immunoassay , recombinant dna , tuberculosis , virology , serology , mycobacterium tuberculosis , chemistry , biology , microbiology and biotechnology , immunology , medicine , biochemistry , pathology , gene
A 26‐kDa antigen has been shown to be a dominant antibody target in Mycobacterium bovis ‐infected cattle. In this study, that antigen was used as an immunogen to raise a panel of mouse monoclonal antibodies. The majority of those bound to native protein with a molecular mass of 26 kDa and to recombinant MPB83, strongly suggesting that MPB83 is an important B‐cell antigenic target in bovine tuberculosis. In order to provide assessment of the potential of measuring antibody responses to the native protein, one monoclonal antibody, 1F11, was incorporated into an enzyme‐linked immunosorbant assay format to trap antigen from a crude bacterial extract. Despite some disadvantages of this format, serum samples from cattle which had been infected experimentally with M. bovis , and from tuberculin skin‐test‐negative and ‐positive field cattle were tested for the presence of antibodies. Data from the skin‐test‐negative cattle allowed an arbitrary cut‐off value to be established and, under these conditions, test sensitivity and specificity were estimated at 37.5 and 89%, respectively. These results indicate potential for MPB83 in the development of assays for serological diagnosis of bovine tuberculosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here